Justice Olayinka Tokode of the Federal High Court, Benin Division, on Tuesday ordered that one Okeke Ifeanyichukwu be remanded in prison custody, for allegedly selling fake, expired and banned drugs.
Prominent among the banned drugs allegedly peddled by the suspect was penis enlargement drugs.
The National Food, Drug Administration and Control (NAFDAC)’s prosecutor, Barrister Bartholomew Simon, listed the fake banned drugs found in the possession of the suspect to include Lisinopril 10mg (Antihypertensive) tables, Penis Enlargement capsules, Tegretol 200mg tables, Salbutamol 2mg tables, Felxican 20mg capsules (piroxicam capsules), and Admdol 100mg(Tramadol)Gelules B. PIUS.
Others are Nemel Nemeclox, (Ampicillin and Cloxacllin) capsules, Buscom 10mg (Antis Pasmodic) tables, Tradmadol 200mg tablets and Atenolol 50mg film coated (Anit hypertensive) tables.
According to the NAFDAC prosecutor, the offence which was committed on March 11, 2016, at No 32, Warake Road, Auchi, contravened counterfeit and fake drugs and unwholesome processed foods (miscellaneous provisions) Act Cap C 34 London 2004 and punishable under Section 3(1) (a) of the same Act.
The accused however pleaded not guilty to the eight count-charge of possession and sales of fake expired and banned drugs.
The presiding judge, Justice Olayinka Tokode, however dismissed the oral bail application by the Defense Counsel, Mr. Razak Etselalumhe.
Tokode, who adjourned the case to June 1 for hearing, directed the Defense Counsel to file a formal bail application, adding that, as soon has the application is filed a date would be fixed for the hearing of the application.
Do You Have Any Story, Press Release, Events Coverage Or You Want An Advert Placement?
Call The DailyBells Nigeria Today On Our Hotlines +234 802 523 7926, +234 806 017 6677 Or WHATSAPP On +234 802 523 7926
Email: email@example.com Or firstname.lastname@example.org.
All Rights Reserved. This Material And Any Other Material On THE DAILYBELLS NIGERIA Should Not Be Reproduced, Published Broadcast, Written Or Distributed In Full Or In Part, Without Written Permission From The Editor/CEO..